Silence Therapeutics (SLNCF) Interest & Investment Income (2020 - 2024)
Historic Interest & Investment Income for Silence Therapeutics (SLNCF) over the last 5 years, with Q3 2024 value amounting to $1.3 million.
- Silence Therapeutics' Interest & Investment Income fell 5081.82% to $1.3 million in Q3 2024 from the same period last year, while for Sep 2024 it was $2.1 million, marking a year-over-year increase of 25350.77%. This contributed to the annual value of $1.8 million for FY2023, which is 1400.47% up from last year.
- According to the latest figures from Q3 2024, Silence Therapeutics' Interest & Investment Income is $1.3 million, which was down 5081.82% from $1.3 million recorded in Q2 2024.
- In the past 5 years, Silence Therapeutics' Interest & Investment Income registered a high of $189.7 million during Q3 2020, and its lowest value of -$4.8 million during Q4 2022.
- In the last 5 years, Silence Therapeutics' Interest & Investment Income had a median value of $425463.5 in 2023 and averaged $11.7 million.
- Data for Silence Therapeutics' Interest & Investment Income shows a peak YoY increase of 115028.85% (in 2022) and a maximum YoY decrease of 1980333.77% (in 2022) over the last 5 years.
- Silence Therapeutics' Interest & Investment Income (Quarter) stood at $290499.2 in 2020, then plummeted by 91.65% to $24264.2 in 2021, then crashed by 19803.34% to -$4.8 million in 2022, then skyrocketed by 110.07% to $481566.9 in 2023, then skyrocketed by 164.68% to $1.3 million in 2024.
- Its last three reported values are $1.3 million in Q3 2024, $1.3 million for Q2 2024, and -$1.0 million during Q1 2024.